(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2...S Supreme Court in 1973 has legalized abortion. Bu... the decision of the Supreme Court. The new law is...state’s voters are allowed to decide the fate of t... 16728 signatures by June 19 on petitions designed...
...ing in Australia's medical schools have become so ... unable to locate important body parts even confus...r doctors including pathologists, anaesthetists an...cerns that medical students are not being properly...
...ha Singh Saini might not enter the Guinness Book o...e much-dreaded Class 12 exam at the age// of 11 de..., 1995, Akansha, daughter of Dhanpat Singh Saini, ...ss 12 exam in the science stream as a regular stud...
...Biswal, the Assistant Commissioner of Prevention, ...ting with the administrative and health officials ...hildren to protect them from Japanese Encephalitis...15 to May 30 and children from one to 15 years of ...
Other Medicine News:Health News:Jaipur Girl’s Rare Feat: The Youngest To Pass Class 12 At The Age Of 1 2Health News:The Department of Health Gears Up To The Arrival Of JE Vaccines 2(Date:9/4/2008)... Ala., Sept. 4 /- Southern Research I...tes of Health (NIH) has selected,the organization ...ries,Probe Production Center Network (MLPCN). The ...rt of the Molecular Libraries Program which is,des...knowledge of the human,genome and validate future ...
(Date:9/4/2008)...ated Survival Data for Ipilimumab to be Presented,...-- Medarex, Inc.,(Nasdaq: MEDX ) announced today ...vestigational anti-CTLA-4 antibody, in melanoma ar...the 33rd Congress of the European Society,for Medi...08 in Stockholm.,Many of the following abstracts w...
(Date:9/4/2008)...ements Remain on Schedule with Two Abstracts Accep...Release in November 2008, BRIDGEWATER, N.J., Sept..., a specialty pharmaceutical company focused on th...e, today announced the appointment of,Peter L. Gar... Peter Garrambone,s career includes more than 50 ...
(Date:9/3/2008)...ina, Sept. 3 /- Simcere,Pha...turer and supplier of,branded generic pharmaceutic...iotech product Endu (also known as Endostar) in Ch...V clinical study., At the request of the SFDA, Si...er validate the safety and therapeutic efficacy of...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 1Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 2Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 3Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 4Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 5CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 1CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 114 3First finding of a metabolite in 1 sex only 119 1First finding of a metabolite in 1 sex only 119 2NanoMed Inc Spins Out of Zyvex Labs 128 1NanoMed Inc Spins Out of Zyvex Labs 128 2... , ,OTTAWA, Canada – March 7, 2007 – L... specializing in developing,advanced products rela...d “good cholesterol,” today announced ...ad product, CRD5. CRD5 is,being developed for the ...sults showed, to date, that CRD5 was safe and that...
...antly reduced the number of,new or enlarged lesion...esentation at upcoming medical meeting -, CAMBRIDG...wswire-FirstCall/ -- Biogen Idec, Inc. and PDL Bio...g CHOICE trial, a Phase 2,randomized, double-blin... primary endpoint in relapsing multiple sclerosis ...
Other Medicine Technology:Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: